News
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Allergens trigger the release of IL-18, which produces ...
2d
News Medical on MSNUniversity of Cincinnati allergist receives $300,000 grant to research rare esophageal disease
A University of Cincinnati researcher has received a three-year, $300,000 grant from the American Academy of Allergy, Asthma & Immunology to investigate the underlying causes of eosinophilic ...
APT-1011 is a novel, proprietary, once daily, investigational oral disintegrating tablet designed to deliver fluticasone propionate to the esophageal mucosa while minimizing residence time in the oral ...
"Erosive Esophagitis Pipeline"The treatment of erosive esophagitis (EE), a severe form of GERD causing esophageal damage, is evolving beyond proton pump inhibitors (PPIs). Despite PPIs being the ...
VICTORIA, British Columbia, May 05, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its ...
If approved, Dupixent would be the first and only treatment indicated in the U.S. for children aged 1- 11 with eosinophilic esophagitis, a disease driven by type 2 inflammation that impacts the ...
Please provide your email address to receive an email when new articles are posted on . All the allergists and immunologists who responded said they collaborate with gastroenterologists. 43% of ...
Dupixent ® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE) Approval based on Phase 3 EoE KIDS trial showing a greater ...
First described nearly 20 years ago, eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus characterized by eosinophilic infiltration of the esophageal epithelium. Over 50% of the ...
Eupraxia continues to observe positive treatment outcomes in its ongoing Phase 1b/2a trial, including for the first time clinical responses measured 9 months after dosing with EP-104GI At 9 months ...
Rationale To date, the exact significance of esophageal eosinophilia requires careful clinical consideration. Traditionally, this finding has been attributed solely to peptic injury, but with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results